228 related articles for article (PubMed ID: 33650207)
1. Effect of eplerenone on choroidal blood flow changes during isometric exercise in patients with chronic central serous chorioretinopathy.
Gallice M; Daruich A; Matet A; Mouvet V; Dirani A; Evequoz G; Geiser M; Behar Cohen F; Chiquet C
Acta Ophthalmol; 2021 Dec; 99(8):e1375-e1381. PubMed ID: 33650207
[TBL] [Abstract][Full Text] [Related]
2. Oral Mineralocorticoid-Receptor Antagonists: Choroidal Parameters Changes Using OCT in Central Serous Chorioretinopathy.
Faghihi H; Mohammadzadeh V; Nabavi A; Faghihi S; Kadivar S; Ghassemi F
Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):726-733. PubMed ID: 31755972
[TBL] [Abstract][Full Text] [Related]
3. Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.
Schwartz R; Habot-Wilner Z; Martinez MR; Nutman A; Goldenberg D; Cohen S; Shulman S; Guzner-Gur H; Loewenstein A; Goldstein M
Acta Ophthalmol; 2017 Nov; 95(7):e610-e618. PubMed ID: 28653813
[TBL] [Abstract][Full Text] [Related]
4. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.
Salz DA; Pitcher JD; Hsu J; Regillo CD; Fineman MS; Elliott KS; Vander JF; Fischer DH; Spirn MJ
Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):439-44. PubMed ID: 25970864
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.
Pichi F; Carrai P; Ciardella A; Behar-Cohen F; Nucci P;
Int Ophthalmol; 2017 Oct; 37(5):1115-1125. PubMed ID: 27757733
[TBL] [Abstract][Full Text] [Related]
6. MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES.
Gergely R; Kovács I; Schneider M; Resch M; Papp A; Récsán Z; Nagy ZZ; Ecsedy M
Retina; 2017 Jun; 37(6):1084-1091. PubMed ID: 27627749
[TBL] [Abstract][Full Text] [Related]
7. Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
Okamoto M; Matsuura T; Ogata N
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):25-32. PubMed ID: 25559505
[TBL] [Abstract][Full Text] [Related]
8. Chronic Neovascular Central Serous Chorioretinopathy: A Stress/Rest Optical Coherence Tomography Angiography Study.
Lupidi M; Fruttini D; Eandi CM; Nicolò M; Cabral D; Tito S; Cagini C; Cardillo Piccolino F
Am J Ophthalmol; 2020 Mar; 211():63-75. PubMed ID: 31715159
[TBL] [Abstract][Full Text] [Related]
9. Retinal Vascular Reactivity in Central Serous Chorioretinopathy.
Cardillo Piccolino F; Lupidi M; Cagini C; Fruttini D; Nicolò M; Eandi CM; Tito S
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4425-4433. PubMed ID: 30193313
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Eplerenone in Chronic Central Serous Chorioretinopathy Refractory to Photodynamic Therapy.
Karagiannis D; Parikakis E; Kontomichos L; Batsos G; Chatziralli I
Semin Ophthalmol; 2019; 34(6):436-441. PubMed ID: 31309849
[No Abstract] [Full Text] [Related]
11. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.
Zhao M; Célérier I; Bousquet E; Jeanny JC; Jonet L; Savoldelli M; Offret O; Curan A; Farman N; Jaisser F; Behar-Cohen F
J Clin Invest; 2012 Jul; 122(7):2672-9. PubMed ID: 22684104
[TBL] [Abstract][Full Text] [Related]
12. Choroidal Vascular Reactivity in Central Serous Chorioretinopathy.
Cardillo Piccolino F; Lupidi M; Cagini C; Fruttini D; Nicolò M; Eandi CM; Tito S
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3897-3905. PubMed ID: 30073350
[TBL] [Abstract][Full Text] [Related]
13. Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.
Rabiolo A; Zucchiatti I; Marchese A; Baldin G; Sacconi R; Montorio D; Cicinelli MV; Querques L; Bandello F; Querques G;
Eye (Lond); 2018 Jan; 32(1):55-66. PubMed ID: 29265111
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.
Willcox A; Culliford L; Ellis L; Rogers CA; Cree A; Chakravarthy U; Ennis S; Behar-Cohen F; Reeves BC; Sivaprasad S; Lotery A
Eye (Lond); 2019 Feb; 33(2):295-303. PubMed ID: 30194380
[TBL] [Abstract][Full Text] [Related]
15. Topical Dexamethasone as an Adjuvant to Mineralocorticoid Receptor Antagonists for the Treatment of Recalcitrant Central Serous Chorioretinopathy.
Wong A; Zhu D; Li AS; Lee JG; Ferrone PJ
Ophthalmic Surg Lasers Imaging Retina; 2022 Dec; 53(12):659-665. PubMed ID: 36547963
[TBL] [Abstract][Full Text] [Related]
16. Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy.
Zola M; Daruich A; Matet A; Mantel I; Behar-Cohen F
Br J Ophthalmol; 2019 Aug; 103(8):1184-1189. PubMed ID: 30355720
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
[TBL] [Abstract][Full Text] [Related]
18. Choroidal blood flow response to isometric exercise in glaucoma patients and patients with ocular hypertension.
Portmann N; Gugleta K; Kochkorov A; Polunina A; Flammer J; Orgul S
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7068-73. PubMed ID: 21828157
[TBL] [Abstract][Full Text] [Related]
19. Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.
Lotery A; Sivaprasad S; O'Connell A; Harris RA; Culliford L; Ellis L; Cree A; Madhusudhan S; Behar-Cohen F; Chakravarthy U; Peto T; Rogers CA; Reeves BC;
Lancet; 2020 Jan; 395(10220):294-303. PubMed ID: 31982075
[TBL] [Abstract][Full Text] [Related]
20. Choroidal blood flow after the first intravitreal ranibizumab injection in neovascular age-related macular degeneration patients.
Mottet B; Aptel F; Geiser MH; Hera R; Zhou T; Almanjoumi A; Vinh V; Chiquet C
Acta Ophthalmol; 2018 Nov; 96(7):e783-e788. PubMed ID: 30203609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
